(Reuters) -Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on ...

But one BDC that has been seemingly firing on all cylinders despite the challenging economic backdrop is Bain Capital Specialty Finance (NYSE:BCSF). Over the past year, the BDC has shown some ...

Bain Capital purchased Kantar in 2019 Bain is a private investment firm headquartered in Boston H.I.G. Capital is a global alternative investment firm Bain Capital portfolio company Kantar Group ...

Bain Capital, a global private investment firm, has proposed to acquire a significant minority shareholding in Dhoot Transmission Private Limited (DTPL) and its associate company, Dhoot Holdings ...

Bain Capital and its affiliates own approximately 39% of the Company’s outstanding common stock, based on the Schedule 13D/A filing dated January 28, 2025. A Special Committee of independent ...

Bain Capital Private Equity proposed to buy the remaining shares of Surgery Partners, an ambulatory surgery center provider in which the private equity firm already has a 39% stake. Under the ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Bain Capital has promoted Ivano Sessa to be co-head of European private equity as the investment firm is shaking up its leadership ranks in the region. The 47-year-old Italian will help lead the ...

The two firms first worked together in 2016 when Bain Capital, a private investment firm ranked 13th globally as of 2023, made its first acquisition in Korea. Bain Capital joined hands with Goldman ...

TOKYO :Mitsubishi Chemical Group picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei reported on Monday.

which seeks to identify and add value to high-quality medical outpatient facilities,” Joe Marconi, partner at Bain Capital, said in a statement.

Bain Capital is considering a possible sale of Italmatch Chemicals SpA, which could be valued at €1.5 billion ($1.6 billion) in a deal, according to people familiar with the matter. The US ...